-
121
Novel combination strategy of high intensity focused ultrasound (HIFU) and checkpoint blockade boosted by bioinspired and oxygen-supplied nanoprobe for multimodal imaging-guided ca...
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
122
Durable responders in advanced NSCLC with elevated TMB and treated with 1L immune checkpoint inhibitor: a real-world outcomes analysis
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
123
Tumor mutational burden quantification from targeted gene panels: major advancements and challenges
Published 2019-07-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
124
Letter to the editor: effects of radiotherapy exposure on fruquintinib plus sintilimab treatment in refractory microsatellite stable metastatic colorectal cancer—a prospective obse...
Published 2025-02-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
125
Into the clinic: Talimogene laherparepvec (T-VEC), a first-in-class intratumoral oncolytic viral therapy
Published 2016-09-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
126
Exosomal circPOLQ promotes macrophage M2 polarization via activating IL-10/STAT3 axis in a colorectal cancer model
Published 2024-05-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
127
PD-L1/TLR7 dual-targeting nanobody-drug conjugate mediates potent tumor regression via elevating tumor immunogenicity in a host-expressed PD-L1 bias-dependent way
Published 2022-10-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
128
Inflamed immune phenotype predicts favorable clinical outcomes of immune checkpoint inhibitor therapy across multiple cancer types
Published 2024-02-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
129
Anti-PD-1 amplifies costimulation in melanoma-infiltrating Th1-like Foxp3+ regulatory T cells to alleviate local immunosuppression
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
130
Glut3 overexpression improves environmental glucose uptake and antitumor efficacy of CAR-T cells in solid tumors
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
131
Immune dysfunction revealed by digital spatial profiling of immuno-oncology markers in progressive stages of renal cell carcinoma and in brain metastases
Published 2023-08-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
132
CD47/SIRPα axis: bridging innate and adaptive immunity
Published 2022-07-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
133
Intratumoral oncolytic virus OH2 injection in patients with locally advanced or metastatic sarcoma: a phase 1/2 trial
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
134
Durvalumab and tremelimumab in combination with metronomic oral vinorelbine for recurrent advanced cervical cancer: an open-label phase I/II study
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
135
High peripheral T cell diversity is associated with lower risk of toxicity and superior response to dual immune checkpoint inhibitor therapy in patients with metastatic NSCLC
Published 2024-12-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
136
Diabetes insipidus and Guillain-Barré-like syndrome following CAR-T cell therapy: a case report
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
137
TCR-engaging scaffolds selectively expand antigen-specific T-cells with a favorable phenotype for adoptive cell therapy
Published 2023-08-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
138
Association of age, race, and ethnicity with access, response, and toxicities from CAR-T therapy in children and adults with B-cell malignancies: a review
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
139
Art of TIL immunotherapy: SITC’s perspective on demystifying a complex treatment
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
140
Targeting Siglec-E facilitates tumor vaccine-induced antitumor immunity in renal carcinoma
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article